We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$422M
AUM Growth
-$18.4M
Cap. Flow
-$25.1M
Cap. Flow %
-5.94%
Top 10 Hldgs %
95.56%
Holding
20
New
3
Increased
9
Reduced
1
Closed
7

Top Buys

1
UBS icon
UBS Group
UBS
+$22M
2
TMUS icon
T-Mobile US
TMUS
+$21.4M
3
C icon
Citigroup
C
+$17.5M
4
LIN icon
Linde
LIN
+$13.2M
5
ATVI
Activision Blizzard
ATVI
+$11.4M

Top Sells

1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$41.6M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$33M
3
AMZN icon
Amazon
AMZN
+$23.2M
4
PM icon
Philip Morris
PM
+$21.1M
5
JPM icon
JPMorgan Chase
JPM
+$15.5M

Sector Composition

1 Healthcare 24.25%
2 Financials 23.93%
3 Consumer Discretionary 18.01%
4 Materials 15.37%
5 Communication Services 11.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALC icon
1
Alcon
ALC
$34.1B
$102M 24.25%
1,257,750
+63,137
+5% +$4.86M
UBS icon
2
UBS Group
UBS
$173B
$65.8M 15.58%
4,096,640
+1,360,934
+50% +$22M
LIN icon
3
Linde
LIN
$238B
$64.9M 15.37%
218,979
+43,476
+25% +$13.2M
STLA icon
4
Stellantis
STLA
$16.8B
$64.5M 15.27%
3,361,065
+477,480
+17% +$9.45M
TMUS icon
5
T-Mobile US
TMUS
$207B
$29.5M 7%
231,290
+153,458
+197% +$21.4M
GS icon
6
Goldman Sachs
GS
$317B
$17.6M 4.18%
46,665
+19,172
+70% +$7.49M
C icon
7
Citigroup
C
$218B
$17.6M 4.17%
+250,551
New +$17.5M
ATVI
8
DELISTED
Activision Blizzard
ATVI
$16.9M 3.99%
217,872
+136,669
+168% +$11.4M
OMC icon
9
Omnicom Group
OMC
$23.3B
$13.2M 3.12%
181,947
-109,650
-38% -$8.15M
DECK icon
10
Deckers Outdoor
DECK
$14.9B
$11.1M 2.62%
184,584
+65,244
+55% +$4.47M
MSFT icon
11
Microsoft
MSFT
$2.94T
$10.9M 2.58%
38,662
+14,631
+61% +$4.26M
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.19T
$7.35M 1.74%
+55,120
New +$7.6M
ABNB icon
13
Airbnb
ABNB
$87B
$496K 0.12%
+2,958
New +$452K
AMZN icon
14
Amazon
AMZN
$2.66T
– –
-134,840
Closed -$23.2M
BIO icon
15
Bio-Rad Laboratories Class A
BIO
$8.11B
– –
-51,223
Closed -$33M
CCEP icon
16
Coca-Cola Europacific Partners
CCEP
$46B
– –
-12,729
Closed -$755K
JPM icon
17
JPMorgan Chase
JPM
$912B
– –
-99,673
Closed -$15.5M
PM icon
18
Philip Morris
PM
$298B
– –
-213,085
Closed -$21.1M
TJX icon
19
TJX Companies
TJX
$171B
– –
-88,253
Closed -$5.95M
VRTX icon
20
Vertex Pharmaceuticals
VRTX
$123B
– –
-206,160
Closed -$41.6M

Similar funds

RCA
Ranch Capital Advisors Sarasota, Florida $277M AUM 22.08% 1-Year Est. Return
TAM
Townsend Asset Management Raleigh, North Carolina $277M AUM 16.26% 1-Year Est. Return
IIA
ICW Investment Advisors Scottsdale, Arizona $277M AUM 12.1% 1-Year Est. Return
TAP
Tounjian Advisory Partners Fort Myers, Florida $277M AUM 21.37% 1-Year Est. Return
TLA
Tanglewood Legacy Advisors Houston, Texas $276M AUM 16.97% 1-Year Est. Return
1NWS
1 North Wealth Services Annapolis, Maryland $277M AUM 15.28% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

Exane Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Exane Asset Management held 20 positions worth $422M, down 4.2% from $441M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Exane Asset Management withdrew a net $25.1M in Q3 2021, closing 7 positions and reducing 1 holding. Its most notable exit was Vertex Pharmaceuticals, an estimated $41.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 36% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Exane Asset Management opened a new position in Citigroup worth $17.6M.

  • Exane Asset Management's largest Q3 2021 buy was Citigroup: 250,551 shares worth $17.6M.
  • Exane Asset Management added most to UBS Group in Q3 2021, an estimated $22M increase.
  • Exane Asset Management's biggest Q3 2021 reduction was Omnicom Group, cutting an estimated $8.15M.
  • Exane Asset Management fully exited Vertex Pharmaceuticals in Q3 2021, selling an estimated $41.6M.
  • Exane Asset Management's ten largest holdings make up 96% of its $422M portfolio in Q3 2021.
  • Exane Asset Management opened 3 new positions and closed 7 in Q3 2021.
  • Exane Asset Management's portfolio value fell 4.2% quarter-over-quarter to $422M.

Based on Exane Asset Management's 13F filing for Q3 2021, filed 19 Oct 2021.